{
    "clinical_study": {
        "@rank": "33369", 
        "arm_group": {
            "arm_group_label": "Extended release tacrolimus (Advagraf\u00ae)"
        }, 
        "brief_summary": {
            "textblock": "To evaluate the clinical efficacy of the extended release formulation of tacrolimus\n      (Advagraf\u00ae) in patients with severe atopic dermatitis, who can not be treated adequately\n      with cyclosporine A because of side effects and/or non-responsiveness."
        }, 
        "brief_title": "Extended Release Tacrolimus (Advagraf\u00ae) in Severe Adult Atopic Dermatitis Patients", 
        "condition": "Atopic Dermatitis", 
        "condition_browse": {
            "mesh_term": [
                "Dermatitis", 
                "Dermatitis, Atopic"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Adult patients with severe atopic dermatitis, uncontrolled by topical treatment\n             (indication for oral immunosuppressive drugs), who are unresponsive to Cyclosporin A,\n             or in which treatment was discontinued because of side effects.\n\n        Exclusion Criteria:\n\n          -  Concomitant use of other oral immunosuppressive drugs and/or UV light therapy\n\n          -  Preexisting abnormalities in liver function, kidney function or haematological\n             abnormalities\n\n          -  History of malignancy within the last 5 years\n\n          -  Uncontrolled hypertension\n\n          -  Pregnancy or lactation; wish for pregnancy during the treatment period\n\n          -  Infections requiring continued therapy\n\n          -  Known positivity for HIV\n\n          -  Evidence of drug and/or alcohol abuse"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Patients with severe atopic dermatitis, who can not be treated adequately with Cycloporin\n        A because of side effects and/or non-responsiveness."
            }
        }, 
        "enrollment": {
            "#text": "10", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 6, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01789619", 
            "org_study_id": "xxx"
        }, 
        "intervention": {
            "arm_group_label": "Extended release tacrolimus (Advagraf\u00ae)", 
            "intervention_name": "Extended release tacrolimus (Advagraf\u00ae)", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Tacrolimus"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "February 8, 2013", 
        "location": {
            "contact": {
                "email": "m.s.debruin-weller@umcutrecht.nl", 
                "last_name": "M S de Bruin-Weller, MD, PhD", 
                "phone": "+31 88 755 7388"
            }, 
            "facility": {
                "address": {
                    "city": "Utrecht", 
                    "country": "Netherlands", 
                    "zip": "3584CX"
                }, 
                "name": "University Medical Center Utrecht"
            }, 
            "investigator": [
                {
                    "last_name": "M S de Bruin-Weller, MD, PhD", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "J van der Schaft, MD", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Netherlands"
        }, 
        "number_of_groups": "1", 
        "official_title": "Extended Release Tacrolimus (Advagraf\u00ae) in Severe Adult Atopic Dermatitis Patients", 
        "overall_contact": {
            "email": "m.s.debruin-weller@umcutrecht.nl", 
            "last_name": "M S de Bruin-Weller, MD, PhD", 
            "phone": "+31 88 755 7388", 
            "phone_ext": "-"
        }, 
        "overall_official": {
            "affiliation": "UMC Utrecht", 
            "last_name": "C AFM Bruijnzeel-Koomen, MD, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Netherlands: Medical Ethics Review Committee (METC)", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Clinical eczema scores", 
            "measure": "Change in Scoring Atopic Dermatitis (SCORAD)", 
            "safety_issue": "No", 
            "time_frame": "Every 4 weeks up to one year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01789619"
        }, 
        "responsible_party": {
            "investigator_affiliation": "UMC Utrecht", 
            "investigator_full_name": "Dr M.S. de Bruin-Weller", 
            "investigator_title": "MD, PhD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Self administered eczema score", 
                "measure": "Change in Patient-Oriented Eczema Measure (POEM)", 
                "safety_issue": "No", 
                "time_frame": "Every 4 weeks up to one year"
            }, 
            {
                "description": "Biomarker atopic dermatitis", 
                "measure": "Change in Thymus and Activation-Regulated Chemokine in serum (TARC)", 
                "safety_issue": "No", 
                "time_frame": "Every 4 weeks up to one year"
            }
        ], 
        "source": "UMC Utrecht", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "UMC Utrecht", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2012", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "February 2013"
    }
}